CIDRAP newsletters options
Declines in prescribing, however, were in certain types of physicians only.
"If we want to protect the American people and our economy, we must defeat the virus everywhere."
Close contact with COVID-19 cases outside of work is the biggest risk factor for infections among American healthcare workers, according to research published yesterday in Emerging Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
US Sen. Sherrod Brown, D-Ohio, announced this week that he has reintroduced legislation to strengthen the federal response to antibiotic resistance.
Data yet to be peer-reviewed show the Omicron variant may be highly transmissible.
The plan comes as the nation records its 2nd and 3rd Omicron cases, in Minnesota and Colorado.
A researcher notes: "Both vaccines are incredibly effective, with only rare breakthrough cases."
The neutralizing monoclonal antibody lenzilumab significantly raised survival without the use of mechanical ventilation in hospitalized COVID-19 patients and had a good safety profile, according to a phase 3 clinical trial yesterday in The Lancet Respiratory Medicine.
The US Department of Agriculture's (USDA's) Animal and Plant Health Inspection Service (APHIS) announced this week that it has begun an effort to study antimicrobial use and resistance on commercial swine farms in the Midwest.
Delta-related COVID-19 activity showed signs of a plateau last week, the WHO says.
The case-patient traveled to South Africa and returned to the San Francisco area on Nov 22 and is isolating at home.
Severe COVID-19 may bring more than twice the risk of dying within a year.
A third dose of the Pfizer/BioNTech mRNA COVID-19 vaccine appears to counteract waning vaccine protection in the short term, according to a preliminary case-control analysis of more than 500,000 coronavirus tests in Israel.
A study conducted in 15 hospitals found that discontinuing contact precautions for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) did not result in increased healthcare-associated infection (HAI) rates, researchers reported today in Infection Control & Hospital Epidemiology.
Also, sequencing found hints that travelers with Omicron likely contracted the virus from different people in different locations.
Those with compromised immune systems get COVID-19 after vaccination 3 times more often—but still rarely—a new study shows.
Merck's pill is on track to be the first approved treatment for COVID-19 infections.
Many COVID-19 survivors experience impaired circulation, abnormal breathing patterns, and chronic fatigue syndrome an average of 9 months after diagnosis, finds a small, single-center study yesterday in JACC: Heart Failure.
Heads of vaccine firms say they can quickly retool existing vaccines to address the variant if needed.
